Lannett Co Inc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for LANNETT CO INC, and what generic and branded alternatives to LANNETT CO INC drugs are available?
LANNETT CO INC has eighty-seven approved drugs.
There is one tentative approval on LANNETT CO INC drugs.
Summary for Lannett Co Inc
| US Patents: | 0 |
| Tradenames: | 68 |
| Ingredients: | 67 |
| NDAs: | 87 |
| Drug Master File Entries: | 1 |
Drugs and US Patents for Lannett Co Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lannett Co Inc | BACLOFEN | baclofen | TABLET;ORAL | 077241-003 | Sep 22, 2021 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| Lannett Co Inc | RANITIDINE HYDROCHLORIDE | ranitidine hydrochloride | SYRUP;ORAL | 078890-001 | Jul 1, 2010 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
| Lannett Co Inc | ATORVASTATIN CALCIUM | atorvastatin calcium | TABLET;ORAL | 091624-001 | Apr 5, 2013 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| Lannett Co Inc | ONDANSETRON HYDROCHLORIDE | ondansetron hydrochloride | INJECTABLE;INJECTION | 090883-001 | Aug 5, 2010 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Paragraph IV (Patent) Challenges for LANNETT CO INC drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Delayed-release Tablets | 20 mg | ➤ Subscribe | 2015-06-03 |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
